Ryan Arthur F 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2026/2/11 申報
- 申報編號
- 0001187443-26-000004
- 申報時間
- 2026/2/11
- 交易日
- 2026/2/9
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 13 筆非衍生性交易。公開市場賣出合計 $7.79 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Ryan Arthur FCIK 0001187443 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/2/9 | Common Stock | S賣出處分 | −1 | $775.63 | −$775.63 | 17,902 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −10 | $776.59F2 | −$7,765.9 | 17,892 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −57 | $777.56F3 | −$44,320.92 | 17,835 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −12 | $778.53F4 | −$9,342.36 | 17,823 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −5 | $779.41F5 | −$3,897.05 | 17,818 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −1 | $780.09 | −$780.09 | 17,817 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −5 | $781.48F6 | −$3,907.4 | 17,812 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −1 | $782.53 | −$782.53 | 17,811 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −3 | $783.34F7 | −$2,350.02 | 17,808 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −1 | $784.59 | −$784.59 | 17,807 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −1 | $785.71 | −$785.71 | 17,806 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −2 | $786.29 | −$1,572.58 | 17,804 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −1 | $787.82 | −$787.82 | 17,803 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents volume-weighted average price of sales of 10 shares of Company stock on February 9, 2026 at prices ranging from $776.04 to $776.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 57 shares of Company stock on February 9, 2026 at prices ranging from $777.02 to $777.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 12 shares of Company stock on February 9, 2026 at prices ranging from $778.11 to $778.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 5 shares of Company stock on February 9, 2026 at prices ranging from $779.13 to $779.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 5 shares of Company stock on February 9, 2026 at prices ranging from $781.05 to $781.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 3 shares of Company stock on February 9, 2026 at prices ranging from $783.20 to $783.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。